Exosome RNA Exosome RNA Research & Industry News
Prediabetes affects millions of people and represents an important warning sign before the development of type 2 diabetes. During this stage, blood sugar levels become elevated, insulin regulation begins to deteriorate, and metabolic disturbances start to develop. Finding safe approaches that can restore metabolic balance before diabetes fully develops is an active area of research.
Researchers from Xinjiang Medical University have now reported that grape-derived exosome-like nanovesicles may help reverse several features of prediabetes in mice.
Exosome-like nanovesicles are tiny membrane-bound particles naturally present in plants. Similar to extracellular vesicles produced by animal cells, these nanoparticles carry biologically active molecules that may influence cellular communication and metabolism.
To investigate their effects, the researchers divided twenty-four mice into four groups. Prediabetes was induced in all animals except the healthy control group. Mice receiving grape exosome-like nanovesicles were treated for eight weeks and compared with untreated animals and mice receiving nutrient supplementation.
The results showed that mice treated with grape exosome-like nanovesicles experienced significant improvements in several important metabolic measurements. Fasting blood glucose levels decreased, two-hour postprandial glucose levels improved, insulin concentrations were reduced, and total cholesterol levels were lower compared with untreated prediabetic animals.
To better understand how these exosome-like particles exerted their effects, the researchers performed metabolomic analysis. They identified several altered metabolites and found that pathways involving tryptophan metabolism and riboflavin metabolism appeared to be particularly important. Both pathways play roles in energy production, immune function, and overall metabolic health.
The team also examined changes in the gut microbiome using 16S rDNA sequencing. While overall microbial diversity remained similar, the composition of bacterial populations changed substantially. Mice receiving grape exosome-like nanovesicles showed increased abundance of Firmicutes and Desulfobacterota, while Bacteroidota and Proteobacteria were more abundant in untreated prediabetic mice.
At the genus level, the abundance of Akkermansia was significantly reduced in treated animals, demonstrating that grape-derived nanovesicles produced notable shifts in gut microbial composition. These changes suggest that interactions between metabolism and the gut microbiome may contribute to the beneficial effects observed.
Although the findings are limited to mice, they suggest that plant-derived extracellular vesicles or exosome-like nanoparticles may offer new approaches for maintaining metabolic health and preventing the progression from prediabetes to diabetes. Additional studies will be needed to determine whether similar benefits can be achieved in humans.
As researchers continue to investigate the therapeutic potential of extracellular vesicles and exosomes, naturally derived nanovesicles from foods such as grapes may provide new opportunities for developing preventive strategies aimed at metabolic diseases.
